Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

Cited by (629)

Items 501–600 of 629

1. KGF and BMP‐6 intervene in cellular reprogramming and in mesenchymal‐epithelial transition (MET) of 3T3L1 mouse adipose cells
   Abu Musa Md Talimur Reza, Sung‐Jin Lee, Supriya Shiwani, Naresh Kumar Singh · 2014 · Cell Biology International
2. Transformation of chicken fibroblasts by the v-fms oncogene
   Teruko Tamura, Angelika Hadwiger-Fangmeier, Bruce Boschek, Heiner Niemann · 1990 · Virology
3. Development of a universal phosphorylated peptide-binding protein for simultaneous assay of kinases
   Wei Li, Lijun Bi, Wenhua Wang, Yongjin Li, Yafeng Zhou, Hongping Wei, Tao Jiang, Lin Bai, Yuanyuan Chen, Zhiping Zhang et al. · 2009 · Biosensors and Bioelectronics
4. Antibodies against highly conserved sites in the epidermal growth factor receptor tyrosine kinase domain as probes for structure and function
   Nancy A. Brown, Larry A. Compton, Gail M. Clinton · 1993 · Biochemistry
5. Preparation and characterization of spin-labeled derivatives of epidermal growth factor (EGF) for investigations of the interactions of EGF with its receptor by electron paramagnetic resonance spectroscopy
   Lee Anne Faulkner-O'Brien, Albert H. Beth, Ioannis A. Papayannopoulos, P. S. R. Anjaneyulu, James V. Staros · 1991 · Biochemistry
6. Cell-membrane hormone receptors: some perspectives on their structure and function relationship
   Cecil C. Yip · 1988 · Biochemistry and Cell Biology
7. Carcinogenesis and intitiation of cell cycling by charge-induced membrane clusters may be due to mitogen receptors and antiports
   J.A. Beech · 1994 · Medical Hypotheses
8. Mammals I: Regulation of RAS Activation
   Antony Wilks Burgess · 1996 · Springer eBooks
9. Exploring 1,3,4-oxadiazole-chalcone hybrids as dual EGFR-resistant mutant inhibitors and antioxidants through in-silico and synthetic approaches
   Shital Manoj Patil, Shashikant V. Bhandari, Ashwini Madgulkar, Smita C. Pawar, Rajesh Yadala, Ipathi Rao urma · 2025 · Journal of Molecular Structure
10. Design, Synthesis, Biological Evaluation and In Silico Studies of Few Novel 2-Substituted Benzothiazole Derivatives as Potential EGFR Inhibitors
    Muhammad Asad Mubeen, Suvarna G. Kini, Avinash Kumar, Karkala Sreedhara Ranganath Pai · 2018 · Letters in Drug Design & Discovery
11. Genetics of Osteosarcoma
    Marc F. Hansen · 2009 · Springer eBooks
12. Positive cooperative effects between receptors induced by an anti-human growth hormone allosteric monoclonal antibody
    Ruben Claudio Aguilar, Viviana C. Blank, Lilia A. Retegui, Leonor P. Roguin · 2000 · Life Sciences
13. Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study
    George P. Stathopoulos, Dimitrios T. Trafalis, J. Dimitroulis, A E Athanasiou, John Koutantos, Αchilles Anagnostopoulos · 2010 · Oncology Letters
14. Strong Epidermal Growth Factor Receptor Expression But Not HER2/neu Expression Correlates with Cell Proliferation in Anal Canal Carcinomas
    Yun Zhong Hui, Amy E. Noffsinger, Mary Ann Miller, Paul E. Hurtubise, Cecilia M. Fenoglio‐Preiser · 1999 · International Journal of Surgical Pathology
15. Fluorescence Investigations of Receptor-Mediated Processes
    William J. Phillips, Richard A. Cerione · 1991 · Springer eBooks
16. Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function
    Tomoyuki Kawamoto, GORDON H. SATO, Kojiro Takahashi, Mieko Nishi, Shigehiko Taniguchi, J. Denry Sato · 1990 · Cytotechnology
17. The EGF/TGFα family of growth factors and their receptors
    William E. Russell, Robert S. Carver · 1998 · Springer eBooks
18. Disulfide‐linked and noncovalent dimers of p185HER‐2 in human breast carcinoma cells
    Yuzhong J. Lin, Tracy A. Christianson, Gail M. Clinton · 1992 · Journal of Cellular Biochemistry
19. Growth factors: the journey continues
    Steven A. Stacker · 2016 · Growth Factors
20. An overview of signal transduction
    Peter J. Parker · 1991 · Molecular aspects of cellular regulation
21. Growth Factor Receptors
    Ivan Damjanov · 1991 · Current topics in pathology
22. Near-Field Microscopy for Biomolecular Systems
    Toshio Yanagida, Eiichi Tamiya, Hiroshi Muramatsu, Patrick A Degenaar, Yoshiharu Ishii, Yasushi Sako, Kiwamu Saito, S. Ohta-Iino, Sachie K. Ogawa, Geard Marriott et al. · 2002 · Springer series in optical sciences/SPringer series in optical sciences
23. Expression of Epidermal Growth Factor Receptor by an Experimental Murine Tumor of Acute Myeloid Leukemia Origin
    Zina Ben-Ishay · 2013 · Acta Haematologica
24. Molecular Docking, Molecular Dynamics Simulation, and Analysis of EGFR-derived Peptides against the EGF
    Samaneh Ghasemali, Safar Farajnia, Atefeh Nazari, Nasrin Bargahi, Mina Mohammadinasr · 2023 · Letters in Drug Design & Discovery
25. EGFR ‐ HER2 Transactivation Viewed in Space and Time Through the Versatile Spectacles of Imaging Cytometry—Implications for Targeted Therapy
    László Ujlaky‐Nagy, János Szöllõsi, György Vereb · 2025 · Cytometry Part A
26. Lateral Mobility of Polypeptide Hormone Receptors and GTP-Binding Proteins
    David A. Jans · 1997 · Molecular biology intelligence unit
27. A Multiscale Molecular Dynamic Analysis Reveals the Effect of Sialylation on EGFR Clustering in a CRISPR/Cas9-Derived Model
    Shwee Khuan Leong, Jye‐Chian Hsiao, Jiun‐Jie Shie · 2022 · International Journal of Molecular Sciences
28. Signalling Pathways Operated by Receptor Protein Tyrosine Kinases
    Bastien D. Gomperts, IJsbrand M. Kramer, Peter E.R. Tatham · 2009 · Elsevier eBooks
29. Role of Lipid Domains in EGF Receptor Signaling
    LINDA JOY PIKE · 2010 · Elsevier eBooks
30. Synthesis, crystal structure, computational, and molecular docking studies of bis {1,1'-[1,3,5-Trimethyl-1,3-phenylenebis(methylene)]di-1H-piperidinium}tetrabromide tri hydrate
    P. Pon Matheswari, R. Nandini Asha, J. Ilavarasi Jeyamalar, P. Selvarathy Grace, Dieter Schollmeyer, B. Ravindran Durai Nayagam · 2022 · Molecular Crystals and Liquid Crystals
31. Designing and In silico Studies of Novel Hybrid of 1,3,4-oxadiazolechalcone Derivatives as EGFR Inhibitors
    Shital Manoj Patil, Shashikant V. Bhandari · 2023 · Current Drug Discovery Technologies
32. Characteristics of the Epidermal Growth Factor Receptor
    Johannes Boonstra, Libert H.K. Defize, Paul M.P. van Bergen en Henegouwen, Siegfried W. de Laat, Arie J. Verkleij · 1989 · Springer eBooks
33. Static and Dynamic Disorder in IN VITRO Reconstituted Receptor–Adaptor Interaction
    Hiroaki Takagi, Miki Morimatsu, Yasushi Sako · 2011 · Advances in chemical physics
34. EGFs and ERBBs—Brief history and prospects
    David F. Stern · 2010 · Seminars in Cell and Developmental Biology
35. Activation of the Human Epidermal Growth Factor Receptor
    Libert H.K. Defize, Johannes Boonstra, Paul M.P. van Bergen en Henegouwen, A. J. Verkley, Siegfried W. de Laat · 1989 · Springer eBooks
36. Signaling by Growth Factor Receptors
    Bose S. Kochupurakkal, Yosef Yarden · 2004 · Humana Press eBooks
37. Ligand-independent oncogenic signaling by the epidermal growth factor receptor
    Julie L. Boerner, Andrew J. Danielsen, Nita J. Maihle · 2003 · Elsevier eBooks
38. The effects of Mitogenic and Metabolic cues on clathrin-mediated endocytosis
    Ralph Christian Delos Santos · 2021
39. Virion-associated US28 rapidly modulates Akt activity to suppress HCMV lytic replication in monocytes
    Jamil Mahmud, Brittany W. Geiler, Juthi Biswas, Michael J. Miller, Julia E. Myers, Stephen M. Matthews, Amanda B. Wass, Christine M. O’Connor, Gary C. T. Chan · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
40. Oncogenic Receptor Tyrosine Kinases
    Mark H. Kirschbaum, Mina D. Marmor, Yosef Yarden · 2003 · Humana Press eBooks
41. Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR
    Peiyuan Sun, Zhuoyi Wang, Ruohan Zhang, Xuanyou Li, Boxing Xu, Rui Shen, Jun Sheng, Jing Wang · 2025 · Scientific Reports
42. A potential mechanism for tetraspanin CD82-mediated regulation of EGFR
    Elisa Lamottke, T. Harma C. Brondijk, Piet Gros · 2026 · Life Science Alliance
43. Ligand regulation and function of preformed EGFR dimers
    Y. Zuo, Hillel T. Schwartz, Kahlil Walker, Long Han, Paul W. Sternberg, Kathryn M. Ferguson · 2026 · Proceedings of the National Academy of Sciences
44. EGFR Receptor Family Extracellular Domain Structures and Functions
    Antony Wilks Burgess, Thomas Garrett · 2008 · Humana Press eBooks
45. Evaluating the in silico activity of bioactive compound iressa, tarceva and capsaicin against epidermal growth factor receptor tyrosine kinase
    Aristatile Balakrishnan · 2013 · African Journal of Pharmacy and Pharmacology
46. Regulation of Cell Proliferation by Receptor Tyrosine Protein Kinases
    IJsbrand M. Kramer · 2015 · Elsevier eBooks
47. Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells
    Ewa Marcinkowska, Elżbieta Gocek · 2016 · Resistance to targeted anti-cancer therapeutics
48. Conformational Transitions in EGFR Protein Tyrosine Kinase Domain and Their Modulation by Mutants
    Eshrat Shaikh, Varun P. Talati, Deepanshu Garg, Ashay Baruah, Priyanka Joshi, Virupaksha Ajit Bastikar · 2024 · Proceedings of the National Academy of Sciences India Section B Biological Sciences
49. Dimerization Activates the Epidermal Growth Factor Receptor Tyrosine Kinase
    Marcel Spaargaren, Libert H.K. Defize, Johannes Boonstra, Siegfried W. de Laat · 1991 · Springer eBooks
50. Single-Molecule Kinetic Analysis of Receptor Protein Tyrosine Kinases
    Michio Hiroshima, Yasushi Sako · 2010 · Springer eBooks
51. Role of epidermal growth factor receptor in malignant pleural mesothelioma and its value for successful chemical pleurodesis
    A. El-Hosainy, Hassan Hosny, Samia Gabal, Sabah Ahmed, Yasmine Hamdy El Hinnawy · 2014 · Egyptian Journal of Chest Diseases and Tuberculosis
52. EGFR Targeted Therapy
    Zorawar Singh Noor, Jonathan Wade Goldman · 2019 · Current cancer research
53. Applications of Optical Biosensors to Structure-Function Studies on the EGF/EGF Receptor System
    Edouard Collins Nice, Bruno Catimel, Julie Rothacker, Nathan E. Hall, Antony Wilks Burgess, Thomas Garrett, Neil M. McKern, Colin Wesley Ward · 2004 · Principles and practice
54. The hepatocyte growth factor receptor (MET): An unconventional transducer of mitogenic and motogenic signals
    Paolo Maria Comoglio · 1996 · Growth factors and cytokines in health and disease
55. Engineering Growth Factor/Receptor Processes: Effects of EGF Receptor Trafficking Dynamics on Cell Proliferation Responses To EGF
    Douglas A. Lauffenburger, C. Starburck, H. Steven Wiley · 1993 · Springer eBooks
56. What the papers say: Do specific interactions between transmembrane helices play a part in signalling transduction? Exploration with the insulin receptor
    Judith Murray‐Rust · 1993 · BioEssays
57. Structural Basis for Ligand-Dependent Transmembrane Signalling of the Insulin and IGF-1 Receptor Kinases
    Jeffrey E. Pessin, Judith L. Treadway · 1989 · Springer eBooks
58. Water Soluble Photochromic Fluorescent Nanoprobes based on Diheteroarylethenes and Polymer Coated Quantum Dots
    Sebastián A. Dı́az · 2013
59. Molecular prognostic markers in breast cancer
    Rajvir Dahiya, Guoren Deng · 1998 · Springer eBooks
60. Interaction Between Proteins and Biological Membranes
    Lorant Janosi, Alemayehu Abebe Gorfe · 2022
61. The Epidermal Growth Factor Receptor: Receptor Dimerization and Signal Transduction
    Gijs F. M. Verheijden, Ingrid Verlaan, Wouter H. Moolenaar · 1991 · Springer eBooks
62. The Biology of K-Ras Signaling Pathways in Pancreatic Cancer
    Helen Court, Mark R. Philips, Dafna Bar‐Sagi · 2013 · Springer eBooks
63. Novel insights in the allosteric activation of the epidermal growth factor receptor
    Nicholas J. Bessman · 2014 · ScholarlyCommons (University of Pennsylvania)
64. Mecanismos moleculares de la degeneración de las motoneuronas en el contexto de la esclerosis lateral amiotrófica
    Karina C. Ricart · 2010 · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
65. A Role For Lipid Rafts In Egfr Tki Resistance In Breast Cancer
    Mary E. Irwin · 2010 · Human Biology
66. Microdomains in the immune system control cell adhesion and pathogen uptake.
    Alessandra Cambi · 2005 · Radboud Repository (Radboud University)
67. Development of Strategies to Manipulate ErbB Receptor Heterodimerization from a Quantitative Analysis of Receptor/Ligand Relationships
    Mark A. Lemmon · 2001
68. B-Raf is an essential component of the mitotic machinery critical for activation of MAPK signaling during mitosis in Xenopus egg extracts
    Sergiy I. Borysov · 2006 · Digital Commons - University of South Florida (University of South Florida)
69. Die Co-Expression der Cyclooxygenase-2 (COX-2) und der Rezeptoren der Epidermal Growth Factor (EGF)-Familie (HER-1, HER-2, HER-3, HER-4) in humanen invasiv-duktalen Mammakarzinomen sowie in Nacktmaus-Modellen
    J Buchwald · 2007 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
70. Antibodies as oncogenes: A hypothesis
    Arie Admon, Stacy H. Shoshan · 2006 · Medical Hypotheses
71. Mutational Analysis of the EGF Receptor Proto-Oncogene
    Joseph Schlessinger, Annemarie Honegger, Axel Ullrich · 1989 · Springer eBooks
72. Is Receptor Oligomerization Causally Linked to Activation of the EGF Receptor Kinase?
    David A. Rintoul · 1992 · Transactions of the Kansas Academy of Science
73. Heterologous Regulation of the Epidermal Grow Factor Receptor
    Marsha Rich Rosner · 1989 · Journal of Toxicology Cutaneous and Ocular Toxicology
74. Regulation of PDGF chain and receptor expression in human malignant mesothelioma cell lines
    Anton W. Langerak · 1995 · RePub (Erasmus University Rotterdam)
75. A Sequence Motif in the Transmembrane Region of Tyrosine Kinase Growth Factor Receptors
    Michael J.E. Sternberg, William John Gullick · 1992 · Springer series in biophysics
76. Identification oftheCysteine Residues Involved inthe Class IDisulfide BondsoftheHumanInsulin Receptor: Properties ofInsulin Receptor Monomers
    Joseph Schlessinger · 1996
77. Einfluss des Tyrosinkinase-Inhibitors Imatinib auf das ErbB3- Receptor Binding Protein1 (Ebp1) in der CML
    Onkologisches Zentrum, Hubertus Wald Tumorzentrum, Carsten Bokemeyer · 2014
78. Intracellular Mechanisms Responsible for Trypsin-induced Increase in Transepithelial Resistance in Intestinal Epithelial Cells
    Aman Wadhwani · 2013 · Libraries and Cultural Resources (University of Calgary)
79. Personalisation of therapy in advanced colorectal cancer
    Jennifer Seligmann · 2015 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
80. Epidermal growth factor receptor family activation and intracellular signaling: Implications for cancer therapeutics
    Judy M. Richman · 2008
81. Cbl in Epidermal Growth Factor Receptor trafficking
    Benedicte Semb Hagen · 2013 · NORA - Norwegian Open Research Archives
82. Structural proteomics : elucidating in vivo structural dynamics of integral membrane proteins by hydroxyl radical footprinting
    Yi Zhu · 2012
83. Caracterización de nuevos perfiles moleculares en carcinoma de endometrio esporádico
    Clara Cieza-Borrella · 2013
84. Multidimensional Microscopy: Application to Membrane Protein Structure
    Andrew H. A. Clayton · 2017 · Springer series in biophysics
85. Identification of Disulfiram as a Potential Therapeutic for RB1 -proficient and -deficient Triple Negative Breast Cancer
    Tyler Robinson · 2014 · TSpace (University of Toronto)
86. Signaling pathways of the endogenous glucagon-like peptide-2 (GLP-2) receptor
    Natalie Walsh · 2001 · Library and Archives Canada (Government of Canada)
87. Heteroreceptor complexes and their allosteric receptor-receptor interactions in the central nervous system. Focus on examples from Dopamine D2 and Serotonin 5-HT1a receptors
    Fidel Corrales · 2017 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
88. Epidermal growth factor-like ligands regulate dimer selection.
    Jamie S. Rush · 2018
89. Role of miRNA-27a Regulation of VAV3 in Cellular and Experimental Models of Sepsis-induced Acute Respiratory Distress Syndrome
    Louis Zhou · 2018 · TSpace (University of Toronto)
90. Toxicity and pharmacokinetic biomarkers for personalized non-small cell lung cancer treatment
    Anna Svedberg · 2020 · Linköping University medical dissertations
91. LRIG1 in lung cancer : prognostic effects and mechanistic studies
    Samuel Kvarnbrink · 2020 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
92. Epidermal growth factor receptor family activation and intracellular signaling
    Judy M. Richman · 2008
93. Clathrin and TOM1L1 regulate epidermal growth factor receptor signaling at the plasma membrane
    Gurjeet Singh Judge · 2021
94. Faculty Opinions recommendation of Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
    Moosa Mohammadi, Andrew Beenken · 2010 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
95. Clathrin and TOM1L1 regulate epidermal growth factor receptor signaling at the plasma membrane
    Gurjeet Singh Judge · 2021
96. Faculty Opinions recommendation of EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms.
    Andrea I. McClatchey · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
97. Quantitative Formats
    Hans Söderlund, Kai Korpela, François Coutlée, Robert H. Yolken, Raphael P. Viscidi, Mary Collins, Richard A. Cardullo, Rudolf Seibl, Stefanie Koehler · 1992 · Springer eBooks
98. Evaluation of cell division cycle associated protein 3 (CDCA3) as a novel prognostic/therapeutic target for EGFR-mutant non-small cell lung cancer
    Katherine B. Sahin · 2022 · Queensland University of Technology
99. Auswirkungen der Rezeptor-Dimerisierung auf das Calcium-imaging muskarinerger Acetylcholinrezeptoren M1, M3 und M5
    Ilya Edip Zengin · 2022
100. Research Status of the Mechanism and Related Risk Factors of Colorectal Adenoma Carcinogenesis
     文涛 杜 · 2022 · Advances in Clinical Medicine